259 related articles for article (PubMed ID: 10667616)
1. The effects of the novel anxiolytic drug lesopitron, a full and selective 5-HT1A receptor agonist, on pupil diameter and oral temperature in man: comparison with buspirone.
Phillips MA; Szabadi E; Bradshaw CM
J Psychopharmacol; 1999 Dec; 13(4):391-7. PubMed ID: 10667616
[TBL] [Abstract][Full Text] [Related]
2. Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis.
Hou RH; Samuels ER; Langley RW; Szabadi E; Bradshaw CM
Psychopharmacology (Berl); 2007 Nov; 195(1):41-59. PubMed ID: 17659380
[TBL] [Abstract][Full Text] [Related]
3. Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.
Fanciullacci M; Sicuteri R; Alessandri M; Geppetti P
Clin Pharmacol Ther; 1995 Mar; 57(3):349-55. PubMed ID: 7697953
[TBL] [Abstract][Full Text] [Related]
4. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
Ballarín M; Carceller A; Guitart X
Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in the rat striatum and nucleus accumbens.
Palacios G; Muro MA; Paz Marín A
Brain Res; 1996 Dec; 742(1-2):141-8. PubMed ID: 9117387
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of clonidine and yohimbine on pupillary diameter at different illumination levels.
Phillips MA; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 2000 Jul; 50(1):65-8. PubMed ID: 10886121
[TBL] [Abstract][Full Text] [Related]
7. Effects of the 5-HT1A receptor agonists buspirone and 8-OH-DPAT on pupil size in common marmosets.
Kotani M; Urushino N; Natsutani I; Ogi Y; Ikeda K
Behav Pharmacol; 2017 Jun; 28(4):313-317. PubMed ID: 27922541
[TBL] [Abstract][Full Text] [Related]
8. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
9. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
10. In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
Nakayama T; Suhara T; Okubo Y; Ichimiya T; Yasuno F; Maeda J; Takano A; Saijo T; Suzuki K
Psychopharmacology (Berl); 2002 Dec; 165(1):37-42. PubMed ID: 12474116
[TBL] [Abstract][Full Text] [Related]
11. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
12. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man.
Bitsios P; Szabadi E; Bradshaw CM
Psychopharmacology (Berl); 1999 Apr; 143(3):286-92. PubMed ID: 10353432
[TBL] [Abstract][Full Text] [Related]
14. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
McAllister-Williams RH; Massey AE
Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521
[TBL] [Abstract][Full Text] [Related]
15. [The serotonin- and dopaminergic mechanisms in the action of 1-pyrimidinyl piperazine derivatives].
Abramets II; Obraztsova OG; Samoĭlovich IM; Kharin NA
Eksp Klin Farmakol; 1992; 55(3):8-11. PubMed ID: 1360856
[TBL] [Abstract][Full Text] [Related]
16. The effects of clonidine on the fear-inhibited light reflex.
Bitsios P; Szabadi E; Bradshaw CM
J Psychopharmacol; 1998; 12(2):137-45. PubMed ID: 9694025
[TBL] [Abstract][Full Text] [Related]
17. Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation.
Blier P; Seletti B; Gilbert F; Young SN; Benkelfat C
Neuropsychopharmacology; 2002 Aug; 27(2):301-8. PubMed ID: 12093604
[TBL] [Abstract][Full Text] [Related]
18. The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with sleep apnea.
Nikolaou A; Schiza SE; Giakoumaki SG; Roussos P; Siafakas N; Bitsios P
Psychopharmacology (Berl); 2008 Feb; 196(2):167-75. PubMed ID: 17899016
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of the fear-inhibited light reflex to diazepam.
Bitsios P; Szabadi E; Bradshaw CM
Psychopharmacology (Berl); 1998 Jan; 135(1):93-8. PubMed ID: 9489938
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
